Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document
Manuel Barreiro-Pérez 1 , Beatriz Cabeza 2 , David Calvo 3 , José Luis Reyes-Juárez 4 , Tomás Datino 5 , Eliseo Vañó Galván 6 , Alicia M Maceira González 7 , Carlos Delgado Sánchez-Gracián 8 , Susanna Prat-González 9 , Rosario J Perea 10 , Gorka Bastarrika 11 , Marcelo Sánchez 10 , Luis Jesús Jiménez-Borreguero 12 , Covadonga Fernández-Golfín Lobán 13 , José F Rodríguez Palomares 14 , José María Tolosana 14 , José Alberto Hidalgo Pérez 15 , Esther Pérez-David 16 , Vicente Bertomeu-González 17 , Hug Cuéllar 4
Magnetic resonance has become a first-line imaging modality in various clinical scenarios. The number of patients with different cardiovascular devices, including cardiac implantable electronic devices, has increased exponentially.
Although there have been reports of risks associated with exposure to magnetic resonance in these patients, the clinical evidence now supports the safety of performing these studies under specific conditions and following recommendations to minimize possible risks.
This document was written by the Working Group on Cardiac Magnetic Resonance Imaging and Cardiac Computed Tomography of the Spanish Society of Cardiology (SEC-GT CRMTC), the Heart Rhythm Association of the Spanish Society of Cardiology (SEC-Heart Rhythm Association), the Spanish Society of Medical Radiology (SERAM), and the Spanish Society of Cardiothoracic Imaging (SEICAT). The document reviews the clinical evidence available in this field and establishes a series of recommendations so that patients with cardiovascular devices can safely access this diagnostic tool.
CITATION Rev Esp Cardiol (Engl Ed). 2023 Mar;76(3):183-196. doi: 10.1016/j.rec.2022.12.002. Epub 2022 Dec 17.